Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryoyu Takeda

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Best Practice & Research. Clinical Endocrinology & Metabolism|August 7, 2012
Subclinical primary aldosteronismYuji Ito, Ryoyu Takeda, Yoshiyu Takeda
Endocrine Journal|March 29, 2021
Pregnancy-associated diabetes insipidus in Japan-a review based on quoting from the literatures reported during the period from 1982 to 2019Ryoyu Takeda, Masashi Demura, Yoshihisa Sugimura, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 8, 2010
Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjectsYuji Ito, Ryoyu Takeda, Shigehiro Karashima, et al.
Hormone Research|December 3, 2003
Treatment of congenital nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride in an adult patientTadashi Konoshita, Masahiro Kuroda, Takashi Kawane, et al.
Internal Medicine (Tokyo, Japan)|June 1, 2004
Significant liver injury with dual positive IgM antibody to Epstein-Barr virus and cytomegalovirus as a puzzling initial manifestation of infectious mononucleosisTakahiro Zenda, Yuji Itoh, Yoshihiro Takayama, et al.
Atherosclerosis. Supplements|November 9, 2004
Effects of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase on serum lipoproteins and ubiquinone-10 levels in patients with familial hypercholesterolemia. 1981Hiroshi Mabuchi, Toshihiro Haba, Ryzo Tatami, et al.
Journal of Atherosclerosis and Thrombosis|February 24, 2005
Risk evaluation of coronary heart disease and cerebrovascular disease by the Japan Atherosclerosis Society Guidelines 2002 using the cohort of the Holicos-PAT studyJunji Koizumi, Masami Shimizu, Susumu Miyamoto, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Best Practice & Research. Clinical Endocrinology & Metabolism|August 7, 2012
Subclinical primary aldosteronismYuji Ito, Ryoyu Takeda, Yoshiyu Takeda
Endocrine Journal|March 29, 2021
Pregnancy-associated diabetes insipidus in Japan-a review based on quoting from the literatures reported during the period from 1982 to 2019Ryoyu Takeda, Masashi Demura, Yoshihisa Sugimura, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 8, 2010
Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjectsYuji Ito, Ryoyu Takeda, Shigehiro Karashima, et al.
Hormone Research|December 3, 2003
Treatment of congenital nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride in an adult patientTadashi Konoshita, Masahiro Kuroda, Takashi Kawane, et al.
Internal Medicine (Tokyo, Japan)|June 1, 2004
Significant liver injury with dual positive IgM antibody to Epstein-Barr virus and cytomegalovirus as a puzzling initial manifestation of infectious mononucleosisTakahiro Zenda, Yuji Itoh, Yoshihiro Takayama, et al.
Atherosclerosis. Supplements|November 9, 2004
Effects of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase on serum lipoproteins and ubiquinone-10 levels in patients with familial hypercholesterolemia. 1981Hiroshi Mabuchi, Toshihiro Haba, Ryzo Tatami, et al.
Journal of Atherosclerosis and Thrombosis|February 24, 2005
Risk evaluation of coronary heart disease and cerebrovascular disease by the Japan Atherosclerosis Society Guidelines 2002 using the cohort of the Holicos-PAT studyJunji Koizumi, Masami Shimizu, Susumu Miyamoto, et al.
Pageof 1